+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Europe Benign Prostatic Hyperplasia Market and Competitive Landscape - 2020

  • ID: 5023450
  • Report
  • April 2020
  • Region: Europe
  • Fore Pharma
1 of 2
The research report Europe Benign Prostatic Hyperplasia Market and Competitive Landscape - 2020, provides comprehensive insights into the Benign Prostatic Hyperplasia pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecasts the Benign Prostatic Hyperplasia market size and drug sales. It also provides insights into Benign Prostatic Hyperplasia epidemiology and late stage pipeline.

This research covers the following: Benign Prostatic Hyperplasia treatment options, Benign Prostatic Hyperplasia late stage clinical trials pipeline, Benign Prostatic Hyperplasia prevalence by countries, Benign Prostatic Hyperplasia market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries Germany, France, Italy, Spain, UK, Europe (EU5 Countries).

Research Scope:
  • Countries: Germany, France, Italy, Spain, UK, Europe
  • Benign Prostatic Hyperplasia pipeline: Find out drugs in clinical trials for the treatment of Benign Prostatic Hyperplasia by development phase 3, phase 2, and phase 1, by pharmacological class and company
  • Benign Prostatic Hyperplasia epidemiology: Find out the number of patients diagnosed (prevalence) with Benign Prostatic Hyperplasia by countries
  • Benign Prostatic Hyperplasia drugs: Identify key drugs marketed and prescribed for Benign Prostatic Hyperplasia in the US, including trade name, molecule name, and company
  • Benign Prostatic Hyperplasia drugs sales: Find out the sales value for Benign Prostatic Hyperplasia drugs by countries
  • Benign Prostatic Hyperplasia market valuations: Find out the market size for Benign Prostatic Hyperplasia drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2024
  • Benign Prostatic Hyperplasia drugs market share: Find out the market shares for key drugs by countries
Benefits of this Research:
  • Evaluate commercial market opportunities for Benign Prostatic Hyperplasia drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in the Benign Prostatic Hyperplasia market
  • Develop in-depth knowledge of competition and markets
  • Analyze Benign Prostatic Hyperplasia drug sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track Market Events and Trends and analyze key events in the Benign Prostatic Hyperplasia market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies
Note: Product cover images may vary from those shown
2 of 2
1. Benign Prostatic Hyperplasia Treatment Options

2. Benign Prostatic Hyperplasia Pipeline Insights
2.1. Benign Prostatic Hyperplasia Phase 3 Clinical Trials
2.2. Benign Prostatic Hyperplasia Phase 2 Clinical Trials
2.3. Benign Prostatic Hyperplasia Phase 1 Clinical Trials

3. Benign Prostatic Hyperplasia Epidemiology Analysis by Countries

4. Germany Benign Prostatic Hyperplasia Market Insights
4.1. Marketed Drugs for Benign Prostatic Hyperplasia in Germany
4.2. Germany Benign Prostatic Hyperplasia Market Size & Forecast
4.3. Germany Benign Prostatic Hyperplasia Drugs Sales Forecast
4.4. Germany Benign Prostatic Hyperplasia Market Share Analysis

5. France Benign Prostatic Hyperplasia Market Insights
5.1. Marketed Drugs for Benign Prostatic Hyperplasia in France
5.2. France Benign Prostatic Hyperplasia Market Size & Forecast
5.3. France Benign Prostatic Hyperplasia Product Sales Forecast
5.4. France Benign Prostatic Hyperplasia Market Share Analysis

6. Italy Benign Prostatic Hyperplasia Market Insights
6.1. Marketed Drugs for Benign Prostatic Hyperplasia in Italy
6.2. Italy Benign Prostatic Hyperplasia Market Size & Forecast
6.3. Italy Benign Prostatic Hyperplasia Product Sales Forecast
6.4. Italy Benign Prostatic Hyperplasia Market Share Analysis

7. Spain Benign Prostatic Hyperplasia Market Insights
7.1. Marketed Drugs for Benign Prostatic Hyperplasia in Spain
7.2. Spain Benign Prostatic Hyperplasia Market Size & Forecast
7.3. Spain Benign Prostatic Hyperplasia Product Sales Forecast
7.4. Spain Benign Prostatic Hyperplasia Market Share Analysis

8. UK Benign Prostatic Hyperplasia Market Insights
8.1. Marketed Drugs for Benign Prostatic Hyperplasia in UK
8.2. UK Benign Prostatic Hyperplasia Market Size & Forecast
8.3. UK Benign Prostatic Hyperplasia Product Sales Forecast
8.4. UK Benign Prostatic Hyperplasia Market Share Analysis

9. Europe Benign Prostatic Hyperplasia Market Insights
9.1. Europe Benign Prostatic Hyperplasia Market Size & Forecast
9.2. Europe Benign Prostatic Hyperplasia Product Sales Forecast
9.3. Europe Benign Prostatic Hyperplasia Market Share Analysis

10. Research Methodology

List of Tables
Table 1: Benign Prostatic Hyperplasia Phase 3 Clinical Trials, Global, 2020
Table 2: Benign Prostatic Hyperplasia Phase 2 Clinical Trials, Global, 2020
Table 3: Benign Prostatic Hyperplasia Phase 1 Clinical Trials, Global, 2020
Table 4: Benign Prostatic Hyperplasia Prevalence by Countries, 2016 - 2024
Table 5: Marketed Drugs for Benign Prostatic Hyperplasia in Germany, 2019
Table 6: Germany Benign Prostatic Hyperplasia Market Size & Forecast ($mn), 2016 - 2024
Table 7: Germany Benign Prostatic Hyperplasia Product Sales ($mn), 2016 - 2024
Table 8: Germany Benign Prostatic Hyperplasia Market Events and Trends, 2016 - 2024
Table 9: Marketed Drugs for Benign Prostatic Hyperplasia in France, 2019
Table 10: France Benign Prostatic Hyperplasia Market Size & Forecast ($mn), 2016 - 2024
Table 11: France Benign Prostatic Hyperplasia Product Sales ($mn), 2016 - 2024
Table 12: France Benign Prostatic Hyperplasia Market Events and Trends, 2016 - 2024
Table 13: Marketed Drugs for Benign Prostatic Hyperplasia in Italy, 2019
Table 14: Italy Benign Prostatic Hyperplasia Market Size & Forecast ($mn), 2016 - 2024
Table 15: Italy Benign Prostatic Hyperplasia Product Sales ($mn), 2016 - 2024
Table 16: Italy Benign Prostatic Hyperplasia Market Events and Trends, 2016 - 2024
Table 17: Marketed Drugs for Benign Prostatic Hyperplasia in Spain, 2019
Table 18: Spain Benign Prostatic Hyperplasia Market Size & Forecast ($mn), 2016 - 2024
Table 19: Spain Benign Prostatic Hyperplasia Product Sales ($mn), 2016 - 2024
Table 20: Spain Benign Prostatic Hyperplasia Market Events and Trends, 2016 - 2024
Table 21: Marketed Drugs for Benign Prostatic Hyperplasia in UK, 2019
Table 22: UK Benign Prostatic Hyperplasia Market Size & Forecast ($mn), 2016 - 2024
Table 23: UK Benign Prostatic Hyperplasia Product Sales ($mn), 2016 - 2024
Table 24: UK Benign Prostatic Hyperplasia Market Events and Trends, 2016 - 2024
Table 25: Europe Benign Prostatic Hyperplasia Market Size & Forecast ($mn), 2016 - 2024
Table 26: Europe Benign Prostatic Hyperplasia Product Sales ($mn), 2016 - 2024

List of Figures
Figure 1: Benign Prostatic Hyperplasia Pipeline by Phase (%), Global, 2020
Figure 2: Benign Prostatic Hyperplasia Prevalence by Countries, 2016 - 2024
Figure 3: Germany Benign Prostatic Hyperplasia Market Size ($mn), 2016 - 2024
Figure 4: Germany Benign Prostatic Hyperplasia Product Sales ($mn), 2016 - 2024
Figure 5: Germany Benign Prostatic Hyperplasia Market Share by Drugs (%), 2019
Figure 6: Germany Benign Prostatic Hyperplasia Market - Future Market Share (%), 2024
Figure 7: France Benign Prostatic Hyperplasia Market Size ($mn), 2016 - 2024
Figure 8: France Benign Prostatic Hyperplasia Product Sales ($mn), 2016 - 2024
Figure 9: France Benign Prostatic Hyperplasia Market Share by Drugs (%), 2019
Figure 10: France Benign Prostatic Hyperplasia Market - Future Market Share (%), 2024
Figure 11: Italy Benign Prostatic Hyperplasia Market Size ($mn), 2016 - 2024
Figure 12: Italy Benign Prostatic Hyperplasia Product Sales ($mn), 2016 - 2024
Figure 13: Italy Benign Prostatic Hyperplasia Market Share by Drugs (%), 2019
Figure 14: Italy Benign Prostatic Hyperplasia Market - Future Market Share (%), 2024
Figure 15: Spain Benign Prostatic Hyperplasia Market Size ($mn), 2016 - 2024
Figure 16: Spain Benign Prostatic Hyperplasia Product Sales ($mn), 2016 - 2024
Figure 17: Spain Benign Prostatic Hyperplasia Market Share by Drugs (%), 2019
Figure 18: Spain Benign Prostatic Hyperplasia Market - Future Market Share (%), 2024
Figure 19: UK Benign Prostatic Hyperplasia Market Size ($mn), 2016 - 2024
Figure 20: UK Benign Prostatic Hyperplasia Product Sales ($mn), 2016 - 2024
Figure 21: UK Benign Prostatic Hyperplasia Market Share by Drugs (%), 2019
Figure 22: UK Benign Prostatic Hyperplasia Market - Future Market Share (%), 2024
Figure 23: Europe Benign Prostatic Hyperplasia Market Size ($mn), 2016 - 2024
Figure 24: Europe Benign Prostatic Hyperplasia Product Sales ($mn), 2016 - 2024
Figure 25: Europe Benign Prostatic Hyperplasia Market Share by Drugs (%), 2019
Figure 26: Europe Benign Prostatic Hyperplasia Market - Future Market Share (%), 2024
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll